Recently, in parallel to our results in high-grade gliomas, TGF-β2 was reported to trigger the expression of V0/V1 and hyaluronan in osteosarcoma cells (Nikitovic et al, 2006). This evidence concerns the gene TGFB2 and central nervous system cancer.